Fintel reports that on May 27, 2026, DA Davidson initiated coverage of Cellebrite DI (NasdaqGS:CLBT) with a Buy recommendation.
Analyst Price Forecast Suggests 74.09% Upside
As of May 14, 2026, the average one-year price target for Cellebrite DI is $22.44/share. The forecasts range from a low of $18.18 to a high of $29.40. The average price target represents an increase of 74.09% from its latest reported closing price of $12.89 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Cellebrite DI is 439MM, a decrease of 11.52%. The projected annual non-GAAP EPS is 0.64.
What is the Fund Sentiment?
There are 232 funds or institutions reporting positions in Cellebrite DI. This is an decrease of 33 owner(s) or 12.45% in the last quarter. Average portfolio weight of all funds dedicated to CLBT is 0.83%, an increase of 15.72%. Total shares owned by institutions increased in the last three months by 0.40% to 127,064K shares. 
The put/call ratio of CLBT is 0.37, indicating a bullish outlook.
What are Other Shareholders Doing?
True Wind Capital Management holds 13,861K shares representing 5.56% ownership of the company. No change in the last quarter.
Voss Capital holds 9,675K shares representing 3.88% ownership of the company. In its prior filing, the firm reported owning 8,050K shares , representing an increase of 16.80%. The firm increased its portfolio allocation in CLBT by 1.60% over the last quarter.
Pertento Partners LLP holds 6,663K shares representing 2.67% ownership of the company. In its prior filing, the firm reported owning 5,959K shares , representing an increase of 10.56%. The firm decreased its portfolio allocation in CLBT by 33.45% over the last quarter.
Phoenix Holdings holds 4,181K shares representing 1.68% ownership of the company. In its prior filing, the firm reported owning 2,511K shares , representing an increase of 39.95%. The firm increased its portfolio allocation in CLBT by 13.52% over the last quarter.
Nine Ten Capital Management holds 3,444K shares representing 1.38% ownership of the company. In its prior filing, the firm reported owning 2,480K shares , representing an increase of 28.00%. The firm increased its portfolio allocation in CLBT by 6.49% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
